Moneycrew , Antiphospholipid Syndrome is a disorder characterized by an increased tendency to form abnormal blood clots ..
I do believe that Leronlimab will have a positive effect here..
---- platelets are recognized more now as also an immune cells,
we can see platelets derive cytokines , which play a role in host defense , but also in hyperimmune state..
And most are regulated by CCL5 , as platelets store inflammatory cytokines including chemokine ligant CCL5 ( rantes )
----Also there is a theory that LL may affect platelets by affecting Neurophillin-1
So yes , IMO yes.
This is probably why we don't see clots in covid patients treated with Leronlimab ...